4 ms·
Start to make patentleft to start competing alongside, and allowing this to be developed. Just like in open source software, all other science departments run
by EGreg 6y ago
Start to make patentleft to start competing alongside, and allowing this to be developed.
Just like in open source software, all other science departments run on a gift economy just fine, everyone contributing small parts to a snowball. Newton stood on the shoulders of giants, he says. He didn’t have a swat team shut him down for it.
The engine of Capitalism is about taking risks and investing capital into a project, to recoup it if it turns into products people want to buy with viable unit economics. That works well, but also has major downsides. Countries like USA which do it wind up paying 10x more for the same drugs as others, and you can see other problems in the OP post about not even developing the drugs. May as well try another system (alongside) like patentleft.
Open source and science is a gift economy where everyone contributes what they can afford, and a growing snowball of ideas. It is built on COLLABORATION rather than competition, and requires NONE of the intrusive government interventions to grant monopolies on ideas and “doctrine of equivalents”. Libertarians and progressives alike should welcome it.
Private property is just a man made system, just like any other. We can look around and see what systems work better. Which is far more popular today:
Wikipedia vs Britannica
WebKit / Blink vs IE
Linux / BSD vs SunOS
The Web vs AOL
Linux/Android vs Nokia
Apache / NGinX vs IIS
Programming languages are almost all open source
Wordpress vs Blogger.com
I could go on... but you get the idea. The tortoise beats the hare eventually.
- vikramkr 6y agoHow does that help? That just reduces the commercial incentive to pay for clinical trials and stuff even more. Phasing out patents doesn't work without an idea for an entirely, fundamentally new system of developing, testing, approving, manufacturing, and distributing drugs. I'm not saying that it's not possible to come up with a radically different system that is better than what we have now, but I am saying that kneecapping the system that we have now without any plan for a replacement definitely isn't going to help.
- EGreg 6y agoIt helps because there are opportunities to create and boost systems of prizes instead of patents.
- vikramkr 6y agoLooks like you edited your comment with a lot of alternate systems, but all the examples you gave are ones that aren't expensive to develop. You have to prove drugs work and take a significant amount of risk that you don't take with software projects like those. And you've added this idea of a prize based system. Who gets the prize in a system without ownership of IP? Again, having a clear alternative before tearing down a system that produces things you want (e.g. new drugs to cure diseases) is kind of important. Just eliminating the system because there will be "opportunities" to figure out better ways of doing things later basically just means eliminating the system completely. Drug development is not a net negative to society. Having a new gene therapy to cure a deadly rare disease that costs way too much and isn't accessible is better than just not having that therapy at all.
- EGreg 6y agoI do have a clear alternative I wrote about it 11 years ago http://magarshak.com/blog/?p=93 http://magarshak.com/blog/?p=93 Costs under a capitalist system of private property and monopolies enforced by government are one thing. Under a system with no profit motive or restrictions on innovation, they are another. We already witness the cost to the US taxpayer. This a lot of money raised by walkathons and public universities and so on. The NIH develops many things and pharma licenses those patents and they don’t pay the public any direct royalties for them. And it devolves into handouts for the large corporations, whether it’s this or banks too big to fail or now with the Fed exceeding its mandate and just making sirect investments into the top corporations to prop up the stock market to restore people’s “confidence” in this system. You talk about cost? The societal cost of the current system is huge, AND the health outcomes and preparedness are far behind what they would be under a system with LESS enforcement private property on such levels. https://youtu.be/HIQk5B0il-A https://youtu.be/HIQk5B0il-A Disclaimer: I am a left-libertarian
- jcranmer 6y agoHave you ever talked to, or even read the writings of, someone who actually does drug development? See for example https://blogs.sciencemag.org/pipeline/archives/2019/05/28/where-drugs-come-from-a-comprehensive-look https://blogs.sciencemag.org/pipeline/archives/2019/05/28/wh... (Derek Lowe does a lot of writing about this). The starting point to realize about drug development is that 90% of our drug candidates fail. And that's only considering candidates that make it to an initial drug filing, which is itself a tiny fraction of compounds considered internally.
- sithadmin 6y ago>Open source and science is a gift economy where everyone contributes what they can afford, and a growing snowball of ideas This doesn't work with pharma. It sort of works for early compound discovery/development, but not for the seriously expensive work: the process chemistry, the animal studies, the human trials, and if all goes well, the costs associated with facing off against adversarial regulatory agencies.
- Jasper_ 6y agoThe problem with pharma development is not the lack of ideas. The majority of those are solely popular because they're free, or heavily subsidized. That's not a viable economic model for doing lots of intense, focused development, and a lot of those above projects lack people doing "boring work", or are subsidized by companies relying on closed-source and patented work to fund the boring stuff.
- sithadmin 6y agoThere's also minimal ethical/moral hazard associated with the projects cited. Pharma trials mean that some nonzero proportion of the study populations will subjected to side effects, some of which may be permanent and debilitating. Some study participants may even die as the result of an adverse event. This is a major disincentive to development that the opensource projects cited never have to face.
- jcranmer 6y ago> Which is far more popular today: But consider all the other cases where open source software hasn't "won": Photoshop v GIMP Maya v Blender Windows v Linux MS Office v LibreOffice IDA Pro v Ghidra There doesn't seem to be a clear trend to me of open source software winning out over closed-source software, or vice versa.
- JoeAltmaier 6y agoFurther, winning today doesn't mean winning tomorrow. Open Source can start to lag behind neighboring technologies (hardware, other packages) and quickly be beat by somebody investing money into support and upgrades. Something open source is very poor at - timely updates.
- EGreg 6y agoIt seems all your examples are on consumer desktop computers. I would even say that iOS and mobile phones promote closed source software and are closed themselves, tightly controlled. And there are many arguments about this, too. Again, I am not saying there aren’t pockets where closed source will hold out for a long time. I am saying why not have an open alternative also? Patentleft movement in pharma